Jens Cardinale

Duesseldorf, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications

Evaluation of the biodistribution of [99mTc]Tc-PSMA-GCK01 SPECT/CT in a prospective, intraindividual comparison with [68Ga]PSMA-11 PET/CT for phenotyping in mCRPC prior to PSMA-targeted radioligand therapy.

Evaluation of the biodistribution of [99mTc]Tc-PSMA-GCK01 SPECT/CT in a prospective, intraindividual comparison with [68Ga]PSMA-11 PET/CT for phenotyping in mCRPC prior to PSMA-targeted radioligand therapy.

Journal: EJNMMI research
Published: March 25, 2026

Diagnostic impact of interpretation criteria for [18F]PSMA-1007 PET/CT: Prospective comparison with CT and bone scan.

Diagnostic impact of interpretation criteria for [18F]PSMA-1007 PET/CT: Prospective comparison with CT and bone scan.

Journal: European journal of nuclear medicine and molecular imaging
Published: January 16, 2026

Scale-up production of [211At]PSMA-5 using automated synthesizer for Investigator-Initiated clinical trial.

Scale-up production of [211At]PSMA-5 using automated synthesizer for Investigator-Initiated clinical trial.

Journal: EJNMMI radiopharmacy and chemistry
Published: November 21, 2025

The analysis of biodistribution and tumor uptake of [18F]AlF-FAPI-74 in patients with soft tissue sarcoma and gastro-intestinal tumors compared with [18F]FDG in a prospective, exploratory study.

The analysis of biodistribution and tumor uptake of [18F]AlF-FAPI-74 in patients with soft tissue sarcoma and gastro-intestinal tumors compared with [18F]FDG in a prospective, exploratory study.

Journal: EJNMMI reports
Published: October 23, 2025

Development of PSMA-Targeted Alpha Therapy Using [211At]PSMA-5.

Development of PSMA-Targeted Alpha Therapy Using [211At]PSMA-5.

Journal: Seminars in nuclear medicine
Published: September 02, 2025

Enhancing reader confidence through dual-time imaging and alternative reconstruction algorithms with [18F]PSMA-1007 PET/CT imaging in local relapsed castration-sensitive prostate cancer?

Enhancing reader confidence through dual-time imaging and alternative reconstruction algorithms with [18F]PSMA-1007 PET/CT imaging in local relapsed castration-sensitive prostate cancer?

Journal: EJNMMI research
Published: August 08, 2025

The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma.

The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma.

Journal: Seminars in nuclear medicine
Published: June 12, 2025

Towards Dual-Tracer SPECT for Prostate Cancer Imaging Using [99mTc]Tc-PSMA-I&S and [111In]In-RM2.

Towards Dual-Tracer SPECT for Prostate Cancer Imaging Using [99mTc]Tc-PSMA-I&S and [111In]In-RM2.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 27, 2025

Pretargeting: Bridging the Two Worlds of Radiopharmaceutical Probes.

Pretargeting: Bridging the Two Worlds of Radiopharmaceutical Probes.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 07, 2025

Biphasic contrast-enhanced [18F]PSMA-1007 PET/CT imaging to improve the detection of local relapse of prostate cancer.

Biphasic contrast-enhanced [18F]PSMA-1007 PET/CT imaging to improve the detection of local relapse of prostate cancer.

Journal: EJNMMI research
Published: February 26, 2025

First-in-human SPECT/CT imaging of [211At]PSMA-5: targeted alpha therapy in a patient with refractory prostate cancer.

First-in-human SPECT/CT imaging of [211At]PSMA-5: targeted alpha therapy in a patient with refractory prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging
Published: November 08, 2024

Comparison Length of Linker in Compound for Nuclear Medicine Targeting Fibroblast Activation Protein as Molecular Target.

Comparison Length of Linker in Compound for Nuclear Medicine Targeting Fibroblast Activation Protein as Molecular Target.

Journal: International journal of molecular sciences
Published: October 27, 2024
Showing 1-12 of 52

Last Updated: 09/26/2026